Gradalis appoints president and CEO
This article was originally published in Scrip
Executive Summary
Privately held biotechnology firm Gradalis has named Joseph M Limber president and chief executive officer. Prior to joining the Dallas, Texas-based firm – which develops drugs, immunotherapies, tools and diagnostics primarily in the area of cancer – Mr Limber was president, CEO and director of Prometheus Laboratories.